10/30/2024
3:30 PM | Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/11/2024
3:49 PM | Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
6:42 AM | Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/08/2024
6:37 AM | Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/09/2024
6:30 AM | Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/02/2024
3:30 PM | Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/01/2024
6:15 PM | Carisma Therapeutics Inc. (Issuer)
Carisma Therapeutics Inc. (Issuer)
Carisma Therapeutics (Issuer)
Scadden David (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
|
07/01/2024
6:16 PM | Carisma Therapeutics Inc. (Issuer)
Carisma Therapeutics Inc. (Issuer)
Carisma Therapeutics (Issuer)
Thorell Marella (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/01/2024
6:17 PM | Carisma Therapeutics Inc. (Issuer)
Carisma Therapeutics Inc. (Issuer)
Carisma Therapeutics (Issuer)
Scadden David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2024
6:19 PM | Carisma Therapeutics Inc. (Issuer)
Carisma Therapeutics Inc. (Issuer)
Carisma Therapeutics (Issuer)
Thorell Marella (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2024
6:37 AM | Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/27/2024
3:54 PM | Carisma Therapeutics Inc. (Issuer)
Carisma Therapeutics Inc. (Issuer)
Carisma Therapeutics (Issuer)
Morrison Briggs (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
3:56 PM | Carisma Therapeutics Inc. (Issuer)
Carisma Therapeutics Inc. (Issuer)
Carisma Therapeutics (Issuer)
ZWEIFACH SANFORD S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
3:40 PM | Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/18/2024
6:05 PM | Carisma Therapeutics Inc. (Issuer)
Carisma Therapeutics Inc. (Issuer)
Carisma Therapeutics (Issuer)
Kelly Steven (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
6:06 PM | Carisma Therapeutics Inc. (Issuer)
Carisma Therapeutics Inc. (Issuer)
Carisma Therapeutics (Issuer)
Klichinsky Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
6:08 PM | Carisma Therapeutics Inc. (Issuer)
Carisma Therapeutics Inc. (Issuer)
Carisma Therapeutics (Issuer)
Morris Richard Steven (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
3:30 PM | Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2024
3:32 PM | Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/28/2024
6:39 PM | Carisma Therapeutics Inc. (Subject)
Carisma Therapeutics Inc. (Subject)
Carisma Therapeutics (Subject)
HealthCap VII, L.P. (Filed by)
| Form SC 13D/A | |
05/09/2024
6:52 AM | Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2024
6:41 AM | Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2024
7:02 AM | Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics (Filer)
| Form DEF 14A | |
04/29/2024
7:05 AM | Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics (Filer)
| Form ARS | |
04/10/2024
7:00 AM | Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/01/2024
5:58 PM | Carisma Therapeutics Inc. (Issuer)
Carisma Therapeutics Inc. (Issuer)
Carisma Therapeutics (Issuer)
Hohneker John (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/01/2024
5:59 PM | Carisma Therapeutics Inc. (Issuer)
Carisma Therapeutics Inc. (Issuer)
Carisma Therapeutics (Issuer)
Hohneker John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2024
7:47 AM | Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
04/01/2024
7:41 AM | Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2024
3:30 PM | AbbVie Biotechnology Ltd (Filed by)
Carisma Therapeutics Inc. (Subject)
Carisma Therapeutics Inc. (Subject)
Carisma Therapeutics (Subject)
| Form SC 13G | |
02/02/2024
3:52 PM | Carisma Therapeutics Inc. (Issuer)
Carisma Therapeutics Inc. (Issuer)
Carisma Therapeutics (Issuer)
Kelly Steven (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
3:53 PM | Carisma Therapeutics Inc. (Issuer)
Carisma Therapeutics Inc. (Issuer)
Carisma Therapeutics (Issuer)
Klichinsky Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
3:53 PM | Carisma Therapeutics Inc. (Issuer)
Carisma Therapeutics Inc. (Issuer)
Carisma Therapeutics (Issuer)
Morris Richard Steven (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
12:06 PM | Carisma Therapeutics Inc. (Subject)
Carisma Therapeutics Inc. (Subject)
Carisma Therapeutics (Subject)
Longview Innovation Corp. (Filed by)
| Form SC 13G/A | |
11/09/2023
7:36 AM | Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/09/2023
6:42 AM | Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
